SEER cancer registry biospecimen research: Yesterday and tomorrow

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 12, 2014, Pages 2681-2687

  Altekruse, Sean F ^a   Rosenfeld, Gabriel E ^a   Carrick, Danielle M ^a   Pressman, Emilee J ^a   Schully, Sheri D ^a   Mechanic, Leah E ^a   Cronin, Kathleen A ^a   Hernandez, Brenda Y ^b   Lynch, Charles F ^c   Cozen, Wendy ^d,e   Khoury, Muin J ^a,f   Penberthy, Lynne T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER BIOSPECIMEN; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RESEARCH; DIAGNOSTIC PROCEDURE; HEALTH SURVEY; HUMAN; MEDICAL HISTORY; MEDICAL RECORD; NATIONAL HEALTH ORGANIZATION; PERSONALIZED MEDICINE; RISK FACTOR; MEDICAL RESEARCH; NEOPLASM; PATHOLOGY; PROCEDURES; QUESTIONNAIRE; UNITED STATES;

BIOMEDICAL RESEARCH; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; RISK FACTORS; SEER PROGRAM; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84919339950     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0490     Document Type: Article

References (46)

1. Goodman MT, Hernandez BY, Hewitt S, Lynch C.F., Cote TR, Frierson HF Jr, et al. Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol 2005; 36: 812-20.
2. Olson JE, Bielinski SJ, Ryu E, Winkler E.M., Takahashi PY, Pathak J, et al. Biobanks and personalized medicine. Clin Genet 2014; 86: 50-55.
3. Warren JL, Klabunde CN, Schrag D, Bach P.B., Riley GF. Overview of the SEER-Medicare data: content, research applications, and gener-alizability to the United States elderly population. Med Care 2002; 40: IV-3-18.
4. Weiner MG, Lyman JA, Murphy S, Weiner M. Electronic health records: high-quality electronic data for higher-quality clinical research. Inform Prim Care 2007; 15: 121-7.
5. Lipson D, Capelletti M, Yelensky R., Otto G, Parker A, Jarosz M., et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012; 18: 382-4.
6. Gu H, Bock C, Mikkelsen T.S., Jager N., Smith ZD, Tomazou E, et al. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 2010; 7: 133-6.
7. Weng L, Wu X, Gao H., Mu B, Li X, Wang J.H., et al. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 2010; 222: 41-51.
8. Altirriba J, Garcia A, Sanchez B., Haba L, Altekruse S, Stratmann T., et al. The sole presence of CDK4 is not a solid criterion for discriminating between tumor and healthy pancreatic tissues. Int J Cancer 2012; 130:2743-5.
9. Anderson WF, Luo S, Chatterjee N., Rosenberg PS, Matsuno RK, Goodman MT, et al Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) Program. Breast Cancer Res Treat 2009; 113: 189-96.
10. Bonner MR, Bennett WP, Xiong W, Lan Q., Brownson RC, Harris CC, et al. Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women. Int J Cancer 2006; 119: 1462-7.
11. Cerhan JR, Natkunam Y, Morton L.M., Maurer MJ, Asmann Y, Habermann TM, et al LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. Leuk Lymphoma 2012; 53: 1105-12.
12. Chang CM, Schroeder JC, Huang W.Y., Dunphy CH, Baric RS, Olshan AF, et al Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res 2010; 34: 190-5.
13. Chang CM, Wang SS, Dave B.J., Jain S., Vasef MA, Weisenburger DD, et al. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer 2011; 129: 938-47.
14. Chaturvedi AK, Engels EA, Pfeiffer R.M., Hernandez BY, Xiao W, Kim E, et al Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301.
15. de Sanjose S., Alemany L, Ordi J., Tous S, Alejo M, Bigby S.M., et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013; 49: 3450-61.
16. Esser AK, Miller MR, Huang Q, Meier M.M., Beltran-Valero de Bernabe D, Stipp CS, et al. Loss of LARGE2 disrupts functional glycosylation of alpha-dystroglycan in prostate cancer. J Biol Chem 2013; 288: 2132-42.
17. Gargano JW, Wilkinson EJ, Unger E.R., Steinau M., Watson M, Huang Y, et al Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis 2012; 16: 471-9.
18. Hernandez BY, Frierson HF, Moskaluk C.A., Li YJ, Clegg L, Cote TR, et al CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum Pathol 2005; 36: 275-81.
19. Hernandez BY, Zhu X, Kwee S., Chan O, Tsai N, Okimoto G., et al. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocel-lular carcinoma. Cancer Epidemiol Biomarkers Prev 2013; 22: 2016-23.
20. Hopenhayn CA, Christian WJ, Watson M, Unger E., Lynch CF, Peters ES, et al. Prevalence of human papillomavirus types in invasive cervical cancers in seven US states prior to vaccine introduction. J Low Genit Tract Dis 2014; 18: 182-9.
21. Iakovlev V, Siegel ER, Tsao M.S., Haun RS. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unre-sectable pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2012; 21: 1135-42.
22. Kwee SA, Hernandez B, Chan O., Wong L. Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival. PLoS ONE 2012; 7:e46591.
23. Lal G, Hashimi S, Smith B.J., Lynch CF, Zhang L, Robinson RA, et al Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa. Ann Surg Oncol 2009; 16: 2280-7.
24. Maskarinec G, Erber E, Verheus M., Hernandez BY, Killeen J, Cashin S, et al Soy consumption and histopathologic markers in breast tissue using tissue microarrays. Nutr Cancer 2009; 61: 708-16.
25. Matsuno RK, Sherman ME, Visvanathan K, Goodman M.T., Hernandez BY, Lynch CF, et al. Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository. Cancer Causes Control 2013; 24:749-57.
26. Mbulaiteye PS, Nathwani BN, Weiss L.M., Rao N., Emmanuel B, Lynch CF, et al Epstein-Barr virus patterns in U.S. Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009. APMIS 2014; 122: 5-15.
27. Morimoto Y, Killeen J, Hernandez B.Y., Mark Cline J, Maskarinec G. Parity and expression of epithelial histopathologic markers in breast tissue. Eur J Cancer Prev 2013; 22: 404-8.
28. Morton LM, Kim CJ, Weiss L.M., Bhatia K., Cockburn M, Hawes D, et al Molecular characteristics of diffuse large B-cell lymphoma in HIV-infected and HIV-uninfected patients in the pre-HAART and pre-ritux-imab era. Leuk Lymphoma 2014; 55: 551-7.
29. Samadder NJ, Vierkant RA, Tillmans L.S., Wang AH, Lynch CF, Anderson KE, et al Cigarette smoking and colorectal cancer risk by Kras mutation status among older women. Am J Gastroenterol 2012; 107:782-9.
30. Samadder NJ, Vierkant RA, Tillmans L.S., Wang AH, Weisenberger DJ, Laird PW, et al Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women. Gastroenterology 2013; 145: 348-56 e2.
31. Sethi S, Ali-Fehmi R, Franceschi S., Struijk L, van Doorn LJ, Quint W, et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer 2012; 131: 1179-86.
32. Shimizu Y, Luk H, Horio D., Miron P, Griswold M, Iglehart D., et al. BRCA1-IRIS overexpression promotes formation of aggressive breast cancers. PLoS ONE 2012; 7:e34102.
33. Song MA, Tiirikainen M, Kwee S., Okimoto G, Yu H, Wong LL Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS ONE 2013; 8:e55761.
34. Steinau M, Unger ER, Hernandez B.Y., Goodman MT, Copeland G, Hopenhayn C, et al Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis 2013; 17: 397-403.
35. Sy MS, Altekruse SF, Li C, Lynch C.F., Goodman MT, Hernandez BY, et al. Association of prion protein expression with pancreatic adeno-carcinoma survival in the SEER residual tissue repository. Cancer Biomark 2011; 10: 251-8.
36. Takikita M, Altekruse S, Lynch C.F., Goodman MT, Hernandez BY, Green M, et al Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. Cancer Res 2009; 69: 2950-5.
37. Verheus M, Maskarinec G, Erber E., Steude JS, Killeen J, Hernandez BY, et al Mammographic density and epithelial histopathologic markers. BMC Cancer 2009; 9:182.
38. Wu AH, Siegmund KD, Long T.I., Cozen W., Wan P, Tseng CC, et al Hormone therapy, DNA methylation, and colon cancer. Carcinogen-esis 2010; 31: 1060-7.
39. Klopfleisch R, Weiss AT, Gruber AD Excavation of a buried treasure - DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histology Histopathol 2011; 26: 797-810.
40. Liu A, Xu X. MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. Methods Mol Biol 2011; 724: 259-67.
41. Szafranska AE, Davison TS, Shingara J, Doleshal M., Riggenbach JA, Morrison CD, et al. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 2008; 10: 415-23.
42. Schweiger MR, Kerick M, Timmermann B., Albrecht MW, Borodina T, Parkhomchuk D, et al Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS ONE 2009; 4:e5548.
43. Fanelli M, Amatori S, Barozzi I., Minucci S. Chromatin immunoprecip-itation and high-throughput sequencing from paraffin-embedded pathology tissue. Nature Protoc 2011; 6: 1905-19.
44. Lemaire R, Desmons A, Tabet J.C., Day R., Salzet M, Fournier I. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 2007; 6: 1295-305.
45. Negishi A, Masuda M, Ono M., Honda K, Shitashige M, Satow R., et al. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma. Cancer Sci 2009; 100: 1605-11.
46. Olson JE, Ryu E, Johnson K.J., Koenig BA, Maschke KJ, Morrisette JA, et al The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc 2013; 88: 952-962.